We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+26.05%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$62.3B
AUM Growth
+$13.8B
(+28%)
Cap. Flow
+$3.01B
Cap. Flow
% of AUM
4.83%
Top 10 Holdings %
Top 10 Hldgs %
42.27%
Holding
775
New
54
Increased
269
Reduced
324
Closed
89
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$1.47B |
| 2 |
Boeing
BA
|
+$959M |
| 3 |
Walt Disney
DIS
|
+$896M |
| 4 |
Salesforce
CRM
|
+$633M |
| 5 |
Intuitive Surgical
ISRG
|
+$407M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$751M |
| 2 |
Procter & Gamble
PG
|
+$623M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$579M |
| 4 |
Merck
MRK
|
+$440M |
| 5 |
Yum China
YUMC
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.89% |
| 2 | Consumer Discretionary | 16.68% |
| 3 | Healthcare | 12.96% |
| 4 | Communication Services | 12.75% |
| 5 | Financials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Enterprise Products Partners
EPD
$82.2B
| $772K | ﹤0.01% |
42,514
+34,134
| +407% | +$610K |
|
452
Unum
UNM
$14.4B
| $771K | ﹤0.01% |
+46,484
| New | +$734K |
|
453
AES
AES
$10.5B
| $757K | ﹤0.01% |
52,273
+3,060
| +6% | +$40.2K |
|
454
Kimberly-Clark
KMB
$36.3B
| $754K | ﹤0.01% |
5,338
+4,012
| +303% | +$554K |
|
455
CME Group
CME
$95.9B
| $741K | ﹤0.01% |
4,561
+4,418
| +3,090% | +$792K |
|
456
PepsiCo
PEP
$189B
| $705K | ﹤0.01% |
5,333
-753
| -12% | -$99.3K |
|
457
Union Pacific
UNP
$174B
| $684K | ﹤0.01% |
4,042
+3,778
| +1,431% | +$605K |
|
458
Intuit
INTU
$90.7B
| $662K | ﹤0.01% |
2,236
+2,138
| +2,182% | +$587K |
|
459
CSX Corp
CSX
$93.3B
| $617K | ﹤0.01% |
26,523
+25,662
| +2,980% | +$568K |
|
460
Williams Companies
WMB
$87.3B
| $607K | ﹤0.01% |
+31,904
| New | +$594K |
|
461
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.29B
| $605K | ﹤0.01% |
5,983
-5,983
| -50% | -$596K |
|
462
Truist Financial
TFC
$63.4B
| $583K | ﹤0.01% |
15,505
+14,995
| +2,940% | +$540K |
|
463
Omnicom Group
OMC
$23.1B
| $582K | ﹤0.01% |
10,657
-5,382
| -34% | -$293K |
|
464
Progressive
PGR
$125B
| $574K | ﹤0.01% |
7,168
+6,954
| +3,250% | +$543K |
|
465
Target
TGT
$69.3B
| $560K | ﹤0.01% |
4,673
-5,920
| -56% | -$676K |
|
|
UN
466
DELISTED
Unilever NV New York Registry Shares
UN
| $547K | ﹤0.01% |
10,266
+253
| +3% | +$12.9K |
|
467
Entergy
ETR
$49.4B
| $507K | ﹤0.01% |
10,800
-746
| -6% | -$36.2K |
|
468
Gen Digital
GEN
$17.6B
| $461K | ﹤0.01% |
+23,225
| New | +$473K |
|
|
BZUN
469
Baozun
BZUN
$171M
| $445K | ﹤0.01% |
11,579
| – | – |
|
|
EFR
470
Eaton Vance Senior Floating-Rate Fund
EFR
$319M
| $431K | ﹤0.01% |
+38,115
| New | +$413K |
|
471
Blackrock
BLK
$175B
| $420K | ﹤0.01% |
772
-344
| -31% | -$174K |
|
472
Lincoln National
LNC
$8.73B
| $304K | ﹤0.01% |
+8,251
| New | +$290K |
|
473
Fox Class A
FOXA
$26.7B
| $286K | ﹤0.01% |
+10,695
| New | +$289K |
|
474
Vanguard Morningstar Growth ETF
VUG
$229B
| $278K | ﹤0.01% |
8,262
-151,014
| -95% | -$4.64M |
|
475
Pfizer
PFE
$155B
| $267K | ﹤0.01% |
8,621
-12,811
| -60% | -$435K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2020 Portfolio in Review
As of Q2 2020, Loomis, Sayles & Company held 775 positions worth $62.3B, up 28% from $48.5B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Loomis, Sayles & Company deployed $3.01B of net new capital in Q2 2020, opening 54 new positions and adding to 269 existing holdings. Its largest new stake was Dropbox: 3,912,402 shares worth $85.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $751M trimmed.
- Loomis, Sayles & Company's largest Q2 2020 buy was Dropbox: 3,912,402 shares worth $85.2M.
- Loomis, Sayles & Company added most to Bank of America Series L in Q2 2020, an estimated $1.47B increase.
- Loomis, Sayles & Company's biggest Q2 2020 reduction was Amgen, cutting an estimated $751M.
- Loomis, Sayles & Company fully exited Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A in Q2 2020, selling an estimated $32.2M.
- Loomis, Sayles & Company's ten largest holdings make up 42% of its $62.3B portfolio in Q2 2020.
- Loomis, Sayles & Company opened 54 new positions and closed 89 in Q2 2020.
- Loomis, Sayles & Company's portfolio value rose 28% quarter-over-quarter to $62.3B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2020, filed 14 Aug 2020.